Portfolio (Quarterly)
Guide ↗
Soleus Capital Management, L.P.
· CIK 0001802630| # | Ticker | Company | Sector | Shares | Value ↓ | % Port | Chg Shares | Chg % | Period Price ① | Since Period ① |
|---|---|---|---|---|---|---|---|---|---|---|
| 41 | TNDM | TANDEM DIABETES CARE INC | Healthcare | 783,000.0 | $15.0M | 0.61% | NEW | — | $19.17 | -21.9% |
| 42 | NRIX | NURIX THERAPEUTICS INC | Healthcare | 938,163.0 | $14.5M | 0.59% | -281K | -23.1% | $15.50 | +12.9% |
| 43 | URGN | UROGEN PHARMA LTD | Healthcare | 727,000.0 | $13.1M | 0.53% | +577K | +384.7% | $17.98 | +60.7% |
| 44 | SION | SIONNA THERAPEUTICS INC | Healthcare | 293,500.0 | $11.8M | 0.48% | +25K | +9.3% | $40.09 | +2.6% |
| 45 | CORT | CORCEPT THERAPEUTICS INC | Healthcare | 285,531.0 | $11.5M | 0.47% | NEW | — | $40.31 | +49.4% |
| 46 | JBIO | JADE BIOSCIENCES INC | Healthcare | 796,744.0 | $11.2M | 0.45% | — | — | $14.05 | +58.1% |
| 47 | VCYT | VERACYTE INC | Healthcare | 319,912.0 | $10.3M | 0.42% | +310K | +3099.1% | $32.21 | +39.8% |
| 48 | IVVD | INVIVYD INC | Healthcare | 7,708,727.0 | $10.0M | 0.41% | — | — | $1.30 | -15.4% |
| 49 | CCCC | C4 THERAPEUTICS INC | Healthcare | 3,803,942.0 | $10.0M | 0.41% | — | — | $2.63 | +35.4% |
| 50 | KIDS | ORTHOPEDIATRICS CORP | Healthcare | 615,447.0 | $9.8M | 0.40% | +90K | +17.1% | $15.87 | +15.8% |
| 51 | RCUS | ARCUS BIOSCIENCES INC | Healthcare | 451,983.0 | $9.8M | 0.40% | -260K | -36.5% | $21.60 | +8.5% |
| 52 | TNGX | TANGO THERAPEUTICS INC | Healthcare | 450,000.0 | $9.4M | 0.38% | +440K | +4400.0% | $20.92 | -3.3% |
| 53 | EOLS | EVOLUS INC | Healthcare | 2,245,360.0 | $9.2M | 0.37% | +1.2M | +109.8% | $4.11 | +48.2% |
| 54 | SOPH | SOPHIA GENETICS SA | Healthcare | 1,850,000.0 | $9.2M | 0.37% | NEW | — | $4.95 | -1.4% |
| 55 | ELVN | ENLIVEN THERAPEUTICS INC | Healthcare | 230,869.0 | $9.1M | 0.37% | -794K | -77.5% | $39.20 | +6.0% |
| 56 | — | INHIBRX BIOSCIENCES INC | — | 131,000.0 | $8.8M | 0.36% | +106K | +424.0% | $67.23 | — |
| 57 | DXCM | DEXCOM INC | Healthcare | 140,000.0 | $8.8M | 0.36% | -1.2M | -89.2% | $62.80 | +14.8% |
| 58 | SEPN | SEPTERNA INC | Healthcare | 275,000.0 | $6.6M | 0.27% | -108K | -28.3% | $24.03 | +18.0% |
| 59 | — | AVALO THERAPEUTICS INC | — | 441,978.0 | $6.6M | 0.27% | — | — | $14.93 | — |
| 60 | BDSX | BIODESIX INC | Healthcare | 416,599.0 | $6.0M | 0.24% | NEW | — | $14.50 | +3.0% |
① Period Price is the implied market price on the last day of the reporting period, calculated as reported value ÷ shares held. It is not the fund's purchase price or cost basis — the fund may have initiated or added to the position at any point during the quarter at a different price. Since Period shows the price change from that quarter-end snapshot to today's last price — it reflects stock movement after the report date, not the fund's actual return.
Sector Allocation
Healthcare
100.0%